pocketful logo light
pocketful logo light
Gland Pharma Ltd logo

Gland Pharma Ltd

NSE: GLAND BSE: 543245

₹2502.90

(0.56%)

Thu, 06 Aug 2026, 09:44 am

mtf coin illustrationMTF 5x

Gland Pharma Share Price Live Chart

1 Day

(0.56%)

No Result Found

Summary

  • Market Cap (in Cr)

    37066.08

  • Net Profit (in Cr)

    698.53

  • P/B

    2.87

  • Sector P/E

    33.76

  • P/E

    37.55

  • EV/EBITDA

    16.18

  • Debt/Equity (Industry)

    0.26

  • Interest Cover (Industry)

    10.81

  • ROCE (Industry)

    16.40

  • RONW (Industry)

    14.39

  • ROE

    7.82

  • ROCE

    11.67

  • Debt/Equity

    0.04

  • EPS (TTM)

    63.37

  • Dividend Yield

    0.89

  • Book Value

    628.68

  • Interest Cover

    26.30

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters51.8351.8351.8351.8351.83
FII7.307.587.917.396.90
DII33.3532.9832.6432.8533.27
Public7.527.617.637.937.99
Government0.000.000.000.000.00

Read More

Technical Analysis

RSI

64.37

MACD

54.30

50 DMA

2386.36

200 DMA

1943.28

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic2949.802714.902608.90248023742245.102010.20
Fibonacci2714.902625.172569.7324802390.272334.832245.10
Camarilla2567.502545.972524.4324802481.372459.842438.30

Pivots Level: Classic

R3

+469.80

2949.80

R2

+234.90

2714.90

R1

+128.90

2608.90

2480
2480
Pivot Point
LTP: 2614.40

S1

-106

2374

S2

-234.90

2245.10

S3

-469.80

2010.20

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    2532.85

  • 20-EMA

    2492.18

  • 30-EMA

    2453.02

  • 50-EMA

    2369.14

  • 100-EMA

    2203.72

  • 200-EMA

    2042.09

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
15 May 2026board-meetingsAccounts, Quarterly Results, Final Dividend
15 May 2026agm
28 Jan 2026board-meetingsQuarterly Results
03 Nov 2025board-meetingsQuarterly Results
14 Jul 2025dividendFinal Dividend - Rs. - 1814 Aug 2025
20 May 2025dividend₹18.00 Dividend /Share14 Aug 2025
20 May 2025agm
16 Jul 2024dividendFinal Dividend - Rs. - 2016 Aug 2024
22 May 2024dividend₹20.00 Dividend /Share16 Aug 2024
22 May 2024agm

Read More

Peer Comparison

Gland Pharma Ltd logo

Gland Pharma Ltd

Cipla Ltd logo

Cipla Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Read More

Gland Pharma Ltd About

Gland Pharma is primarily engaged in manufacturing injectable formulations. The Company’s shares are listed on BSE Limited and National Stock Exchange of India Limited.

Industry

Pharmaceuticals - Indian - Formulations

Founded

1978

Headquarters

CEO

SRINIVAS SADU

Employees

Contact

Website icon

Website

http://www.glandpharma.com

Email icon

Email

investors@glandpharma.com

Phone icon

Phone

91-40-30510999

Location icon

Location

Sy No 143-148 150&151 Nr Gandi, X Roads D P Pally Dundigal, Hyderabad, Telangana, 500043

Read More

Gland Pharma Ltd Company History

YearHistory
2019
  • The company filed Dexrazoxane for Injection, its first filing with the National Medical Products Administration, China, and received clinical waiver
2020
  • Gland Pharma along with its partners MAIA Pharmaceuticals, Inc. and Athenex Pharmaceutical Division announce the launch of a Ready-to-Use Bivalirudin Injection in the United States of America
2021
  • Gland Pharma received approval for generic Foscarnet Sodium Injection, Single-Dose Bag for Infusion
  • Gland Pharma receives Tentative Approval for Sugammadex Injection
  • Gland Pharma receives tentative approval for Cangrelor injection
2022
  • Gland Pharma enters into put option agreement to acquire 100% of Cenexi Group
  • Gland Pharma announces launch of Bortezomib for Injection in US market
2024
  • The Company received approval from the United States Food and Drug Administration (US FDA) for Plerixafor Injection

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUNDbulkBuy10162191588.6921 Mar 2025
VANGUARD EMERGING MARKETS STOCK INDEX FUND A SERIES OF VIEIFbulkBuy8385561588.6921 Mar 2025
FOSUN PHARMA INDUSTRIAL PTE. LTD.bulkSell99000001771.8119 Jun 2024
UBS PRINCIPAL CAPITAL ASIA LIMITEDbulkBuy8250001771.0519 Jun 2024
LAKUMI TRUSTbulkSell61654861739.109 Apr 2024
NICOMAC MACHINERY PRIVATE LIMITEDbulkSell19554521735.3109 Apr 2024
BNP PARIBAS ARBITRAGEblockSell2577611936.9525 Jan 2024
SOCIETE GENERALEblockBuy2577611936.9525 Jan 2024
GRAVITON RESEARCH CAPITAL LLPbulkSell11103001700.0209 Aug 2023
GRAVITON RESEARCH CAPITAL LLPbulkBuy11103001698.7209 Aug 2023

Read More

Gland Pharma Ltd News

Gland Pharma gets USFDA nod for Sugammadex

Gland Pharma Limited secures USFDA approval for Sugammadex Injection, a reversal agent with USD 1.6 billion US sales. The product launches Day 1 via marketing partner.

29 Jul 2026

companies

Gland Pharma: ₹51.59 Cr Block Trade on NSE

Gland Pharma sees a block trade of ₹51.59 crores on NSE involving ~209,098 shares at ₹2467.40 per share.

29 Jul 2026

equity-markets

Gland Pharma AGM set for Aug 25, 2026

Gland Pharma Limited has scheduled its 48th Annual General Meeting for August 25, 2026. The meeting will be held via video conferencing, with shareholders required to register email IDs to access documents.

28 Jul 2026

companies

Gland Pharma to host Q1 FY27 earnings call on Aug 10

Gland Pharma Limited will hold an earnings conference call on August 10, 2026, at 6:30 PM IST to discuss its financial performance for the quarter ended June 30, 2026. The transcript and audio recording will be available on the company's website post-call.

24 Jul 2026

companies

Gland Pharma appoints two independent directors

Gland Pharma shareholders approved the reappointment of Mr. Udo Johannes Vetter and the appointment of Mr. William Robert Keller as Independent Directors. All five resolutions put to vote via postal ballot were passed with the requisite majority.

20 Jul 2026

companies

Read More

Frequently Asked Questions

  • 1.What is the stock price of Gland Pharma Ltd?

    As of 06/08/2026 at 3:14 PM, Gland Pharma Ltd shares are trading at ₹2502.90.

  • 2.What is the market cap. of Gland Pharma Ltd?

    As of 06/08/2026, the market capitalization of Gland Pharma Ltd is ₹41,312.50 crore.

  • 3.When was Gland Pharma Ltd founded?

    Gland Pharma Ltd was founded in 1978.

  • 4.What are the P/E and P/B ratios of Gland Pharma Ltd?

    As of 06/08/2026, Gland Pharma Ltd has a P/E ratio of 40.16 and a P/B ratio of 2.87.

  • 5.How can I buy shares of Gland Pharma Ltd?

    You can buy shares of Gland Pharma Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.

  • 6.What is the shareholding pattern of Gland Pharma Ltd?

    As of March,2026, promoters hold 51.83% in Gland Pharma Ltd, while FIIs, DIIs and public shareholders hold 7.30%, 33.35% and 7.52%, respectively. The government holds 0.00%.

  • 7.Does Gland Pharma Ltd pay dividends?

    Yes, Gland Pharma Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹Final Dividend - Rs. - 18 per share.

  • 8.What is the dividend yield of Gland Pharma Ltd?

    As of 06 August, 2026, the dividend yield of Gland Pharma Ltd stands at 0.72%.

  • 9.What are the latest financial results of Gland Pharma Ltd?

    For January,2024, Gland Pharma Ltd reported revenue of ₹5,590.00 crore and a net profit of ₹699.00 crore.

  • 10.What is the Stock symbol of Gland Pharma Ltd?

    GLAND is the stock symbol of Gland Pharma Ltd.

  • 11.Who is the CEO of Gland Pharma Ltd?

    The CEO of Gland Pharma Ltd is SRINIVAS SADU.

Open Your Free Demat Account

Enter your phone number